Posted on December 05, 2016
On Nov. 21, the MHA Keystone Center hosted a webinar on mitigating the risk associated with the use of the LivaNova PLC (formerly Sorin Group Deutschland GmbH) Stockert 3T Heater-Cooler Systems. The webinar highlighted resources from the Centers for Disease Control and Prevention (CDC) and the U.S. Food & Drug Administration (FDA) as it pertains to risk mitigation, education for clinicians, and the follow-up process for potentially affected patients. The CDC provides templates to inform primary healthcare providers and patients, along with letters for concerned patients to bring to their primary care provider. The FDA has compiled a thorough list of current practices to reduce the risk of infection to patients.
An MHA Keystone member hospital shared their experience of how they identified potentially affected individuals, their process of notification, and ultimately how they structured their patient screening program. The webinar and additional resources can be found on the MHA Community.
Research will continue to identify emerging diagnostic features and new mitigation strategies. As such, the MHA Keystone Center will continue to provide updates as new information is released. If you have any questions, please contact Matt Grove at the MHA Keystone Center.
Tags: MHA Keystone Center, Patient Safety & Quality, LivaNova PLC, Heater-Cooler
Posted in: Patient Safety & Quality
Media inquiries: contact Laura Wotruba at (517) 703-8601.
Other inquiries: email email@example.com
Read the MHA policy on publication via MHA media.
Michigan Health & Hospital Association
Watch the video »
2112 University Park Dr.
Okemos, MI 48864
Phone: (517) 323-3443
Fax: (517) 323-0946
MHA Capitol Advocacy Center
110 W. Michigan Ave.
Lansing, MI 48933
Phone: (517) 703-8601
Fax: (517) 703-0628
All contents and materials © Copyright Michigan Health & Hospital Association
Contact | Privacy & Terms